About: Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on October 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в жовтні 2009 (uk) مقالة علمية نشرت في أكتوبر 2009 (ar) scientific article published on October 2009 (en)
publication date	wds:Q37393984-7F39F6BE-BFFC-49A8-9BD2-09619293269F
publication date	2009-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37393984-317CC656-FFD3-4080-8248-9CA204943CC7
language of work or name	English
cites work	wds:Q37393984-03A3E5A2-52EC-45F5-884C-809AD9B5F14E wds:Q37393984-0F985340-7438-46CC-8B7A-B721C57320AD wds:Q37393984-2B09E821-D9A5-4EAE-86B3-1D31FF13AAFF wds:Q37393984-2CA79E78-2323-4EB5-A582-FEA673EA699E wds:Q37393984-385C4EA6-F82D-48D1-95C4-4C2D589461CB wds:Q37393984-4228F502-5089-4325-980A-6F96F8DD0984 wds:Q37393984-4B93A3A8-3265-4607-B61E-92FAB9CFF0AB wds:Q37393984-512E12D9-34F1-48B3-BCE9-FEB7CBBCED39 wds:Q37393984-6C268D52-B052-41F4-99BE-D63588C1B5F4 wds:Q37393984-6FD085E0-99C7-4AD2-B6F9-F9D84D22BC40 wds:Q37393984-788EFC4E-C7E6-4903-A719-8C3A34A36C79 wds:Q37393984-84977FDC-2A1C-4BA5-B481-212F43032693 wds:Q37393984-8AD42D19-BAF1-4A22-88A1-08C981AC444E wds:Q37393984-8DFA1ADD-9C1B-414C-B649-2AF9C214A650 wds:Q37393984-8E838AFB-8E86-4A46-9334-C9E5C042AFA7 wds:Q37393984-95C3CFA1-0E70-4C52-958C-3739E6D9161B wds:Q37393984-B2A43F3F-451D-41CF-9A1D-ABB5487B0B78 wds:Q37393984-CA51F927-34F7-46B9-96DE-08DD2E85A128 wds:Q37393984-D3760CC0-D953-4C7F-9290-D1F573BE5F15
cites work	Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Analyzing data from ordered categories Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells. The effects of diphenylhydantoin on murine astrocytoma radiosensitivity. [Effects of phenobarbital on the metabolism of ACNU in vivo] [The interactions of antiepileptic drugs in oncology practice] Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies
author name string	wds:Q37393984-28266DCA-37D2-4A09-884C-509603719031 wds:Q37393984-48998BBB-4095-4B98-90FF-A74E91C1F982 wds:Q37393984-E09C9BC8-A109-49CA-9F14-78C1770AEAFF wds:Q37393984-F81D6BB3-C83D-4BE0-A80D-159D89D70145
author name string	Karla Ballman Kurt A Jaeckle Jan C Buckner Alfred Furth
rdfs:label	Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (en) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (nl) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (ast)
skos:prefLabel	Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (en) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (nl) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (ast)
name	Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (en) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (nl) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (ast)
title	wds:Q37393984-A00B56AA-9FB0-4AE3-9AE2-4719B3B4C4AE
title	Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma (en)
page(s)	wds:Q37393984-8CE3251C-E64F-4B51-A859-DDEE2A3FE6A2
page(s)	1207-1213
instance of	wds:Q37393984-1A5562D8-B5DC-4250-9DB3-EE8AE945DD14
instance of	scholarly article
PubMed ID	wds:Q37393984-9EC2E1F7-E494-4FD6-AB37-38E18CA5D9DB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19822870
PubMed ID	19822870
published in	wds:Q37393984-82CAF4C5-B268-4093-8719-6E8E0F48073F
published in	Neurology
issue	wds:Q37393984-B141D730-8107-4E3C-B10D-C4995F578F18
volume	wds:Q37393984-103B71B7-E2BE-47ED-8B93-D9EA0395BCD4
issue	15
volume	73
DOI	wds:Q37393984-273712D7-4F03-4D20-8888-BBCED531E420
DOI	http://dx.doi.org/10.1212/WNL.0B013E3181BBFECA
DOI	10.1212/WNL.0B013E3181BBFECA
PMCID	wds:Q37393984-B726A82D-5055-4EE0-9340-C6753304A3E9
PMCID	2764724
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37393984
is cites work of	Seizure prognosis in brain tumors: new insights and evidence-based management In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software